Using anti-BRCA1 antibodies AP16 and K-18 on frozen sections we found punctate BRCA1 staining and more homogeneous staining with the MS110 antibody in variable numbers of tumor cell nuclei and nucleoli of breast cancer patients[26,27]. This evidence concerns the gene BRCA1 and breast cancer.